NMFC Post-Earnings: Analyst Cuts Target as BDC Sector Pulls Back

NMFC has just cleared its Q3 print, but the news flow hasn't stopped: Wells Fargo moved to cut its price target within hours of the earnings release, and the stock slipped back on Tuesday even as the week remained modestly positive for the BDC sector.

The analyst pressure on NMFC has been a one-way street for over a year. Wells Fargo's Finian O'Shea trimmed his target to $7.00 from $7.50 on November 4, maintaining an Equal-Weight rating, the third time he has lowered his target in 2026. Keefe Bruyette and B. Riley have both followed a similar pattern, with cuts in July and March respectively. The consensus direction is clear: no one is upgrading, targets are coming down in steps, and the mean price target of $10.00 cited in older data predates this year's resets entirely and should be disregarded. With NMFC closing at $7.01, O'Shea's freshly cut $7.00 target puts the stock essentially at fair value by his measure, the tightest that gap has been in this cycle. The stock trades at 0.64 times book, a discount that reflects persistent concerns about net asset value erosion as credit conditions remain uncertain.

Positioning in the lending market has continued the loosening trend that defined the pre-earnings period, though with a slight reversal in availability since Monday. Availability has pulled back to 88%, down from a high near 99% last week but still dramatically above the 38-to-45% range that characterised much of October. Short interest edged lower again to around 3.04 million shares, now down nearly 4.6% on the week and more than 6.5% over the past month. Borrowing costs have also continued to ease, reaching 3.58%, the lowest reading in the 30-day window and roughly half the level seen at the start of October. The ORTEX short score has dipped to 58.4 from a recent peak above 60, consistent with the broader de-escalation of bearish conviction. Options positioning stays firmly call-skewed: the put/call ratio of 0.016 remains near its 52-week low of 0.015 and well below the 20-day average of 0.029.

Where the ownership picture adds texture is in the buyback data from ORTEX Alt Data. NMFC logged its largest second quarter for shares repurchased since records began in 2024, with 1,122,761 shares bought back in Q2, up 21% on the same quarter last year. That commitment to returning capital at current prices echoes the insider buying cluster from March, when Steven Klinsky spent roughly $4.6 million across several open-market purchases at prices around $8.05 to $8.17. Klinsky, the firm's founder and a 10%-plus owner, holds a Schedule 13D on file with the SEC as of March 12, an activist-style filing that signals active intent rather than passive accumulation. His stake stands at approximately 12.5% of shares outstanding as last disclosed, though the standard caveat applies: 13D positions are reported around the 5% threshold and may have changed since filing.

The peer group moved in broadly the same direction this week. ARCC gained 2.7% and FSK rose 4.4%, while OCSL added 4.6%, all outpacing NMFC's 2.2% weekly gain. Tuesday's pullback hit the whole sector, with ARCC off 2.1% and FSK down 2.7% on the day alongside NMFC's 1.4% decline. The day-one reaction to the Q3 print was muted, a loss of roughly 0.3%, consistent with the market treating the results as broadly in line rather than a catalyst in either direction.

The next scheduled earnings event is not until late February 2027. Between now and then, the question worth watching is whether the analyst target-cutting cycle has found a floor at or just below the current price, or whether further NAV pressure prompts another round of revisions.